Aug. 2, 2011
/PRNewswire/ -- Grifols, a global healthcare company and biopharmaceutical manufacturer based in
, has announced the structure of its new North American Commercial Operations. Under the new Commercial Operations structure, the U.S. commercial group will be organized by product portfolio to better serve patients and customers throughout
. The Canadian organization, a major presence within North American operations, will remain structurally unchanged.
"By creating cross-functional teams for the major product areas, the sales, marketing, and business functions can work more closely together toward customer-specific goals and objectives," said
, President and CEO of Grifols' North American operations. "This will provide greater focus for our teams and permit us to build upon our existing customer partnerships as well as establish new ones," continued Mr. Rich. Dedicated national accounts and managed care teams will complement the product portfolio-based sales and marketing teams.
will serve as the president of Grifols' North American Commercial Operations. Mr. Abelson was formerly head of Talecris' International Commercial Operations. In his new position, he will oversee the marketing and sales strategy for all of Grifols' North American products. Mr. Abelson has nearly 20 years of senior management experience in the healthcare industry and was responsible for Talecris' commercial operations in all markets outside of
the United States
Grifols' North American Commercial Operations will be supported by a team of experienced professionals with a proven track record of meeting patient and customer needs in the plasma therapeutics industry and the general healthcare arena.
- Bill Zabel, Vice President and General Manager of IVIG/Albumin/Hypermune Products
Mr. Zabel has more than 20 years of healthcare leadership experience, and he has worked in the biological therapeutics industry for more than a decade. He previously served as Talecris' U.S. Vice President of Sales and held senior commercial positions in Bayer Healthcare Corporation.
- Whitney Herd, Vice President and General Manager of Hematology/Diagnostics/Hospital Products
Ms. Herd has nearly 16 years of healthcare leadership experience working both in biopharmaceutical and diagnostic companies. Ms. Herd previously served as Vice President and General Manager of Grifols U.S. Bioscience portfolio.
- Lafmin Morgan, Vice President and General Manager of Pulmonary Products
Mr. Morgan previously served as Talecris' Vice President of U.S. Product Management. He joined the organization in 2010 from GlaxoSmithKline, where he served twenty years in various finance, sales, commercial strategy, and marketing roles across a variety of therapeutic areas.